RxDoctor Payments Data

Tanzeen Ahmed, MD

Hospitalist · Fort Myers, FLNPI 1437140480

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,462 of the $3,358 with a category attached, or 73.3%. 7 manufacturers reported payments, led by Johnson & Johnson at 41.8% of the total. Reporting peaked in 2023 at $1,476 and has fallen 83.6% since, to $242 in 2025. Among hospitalist clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,358in general payments, 2019–2025

Across 32 payments — averaging $104.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$1K
  • Intuitive Surgical$897
  • AstraZeneca$474
  • Paratek Pharmaceuticals, Inc.$324
  • Actelion Pharmaceuticals US, Inc.$121
  • United Therapeutics Corporation$98
  • plus $41 from 1 others

What the payments were for

  • Travel & lodging$89727%
  • Food & beverage$2,46273%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,358 in reported general payments places this provider in the 95th percentile of 1,570 hospitalist providers in Florida.

See all hospitalist providers in Florida

Medicare billing

Part B allowed, 2024
$59,162
Medicare patients
257
Services billed
852

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin12$11,651
Novolog Mix 70-30 FlexpenInsulin Aspart Prot/Insuln Asp13$1,723
Amlodipine Besylate105$1,076
Metoprolol Succinate61$880
Atorvastatin Calcium87$847
Omeprazole33$587
Tamsulosin Hcl35$485
Losartan Potassium66$447
Oxybutynin Chloride14$396
Levothyroxine Sodium26$379
Mirtazapine13$353
Rosuvastatin Calcium28$340
Lisinopril34$257
Pantoprazole Sodium46$251
Fluticasone Propionate13$221

Paid to pharmacies, not to this prescriber.

Other hospitalist in Fort Myers

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →